(NYSE: CBT) Cabot's forecast annual revenue growth rate of 2.79% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.62%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.83%.
Cabot's revenue in 2026 is $3,575,000,000.On average, 8 Wall Street analysts forecast CBT's revenue for 2026 to be $188,160,064,965, with the lowest CBT revenue forecast at $178,042,267,233, and the highest CBT revenue forecast at $201,891,361,887. On average, 8 Wall Street analysts forecast CBT's revenue for 2027 to be $194,096,527,920, with the lowest CBT revenue forecast at $180,365,230,998, and the highest CBT revenue forecast at $209,221,603,101.
In 2028, CBT is forecast to generate $200,549,205,045 in revenue, with the lowest revenue forecast at $186,869,529,540 and the highest revenue forecast at $215,519,415,975.